Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06017050 · ClinicalTrials.gov registry record · NA
BullyDown, a Text Messaging-based Bullying Prevention Program for Middle School-aged Youth
A NA study of Bullying, sponsored by Center for Innovative Public Health Research.
- Completed
- Registry status
- NA
- Development phase
- 138
- Enrollment target
- 2
- Study locations
NCT06017050 is a NA study of Bullying that has completed, run by Center for Innovative Public Health Research. The registered enrollment target is 138 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT06017050, a NA study of Bullying, has completed, sponsored by Center for Innovative Public Health Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 138 participants
- Enrollment target
- 2
- Study locations
Study Summary
Given the limited impact of existing school-based interventions and the time associated with implementing them during school time, more efficient and effective intervention methods are needed. Programs that can be delivered to middle school youth irrespective of whether they are attending school physically or virtually may be especially relevant as school boundaries become more fluid. BullyDown addresses this critical need by providing a scalable program that could be quickly and cost-effectively disseminated nationally.
Conditions Studied
Interventions
- BEHAVIORAL BullyDown
- BEHAVIORAL Attention-matched control
Study Locations (2)
California
- Center for Innovative Public Health Research - San Clemente
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2023-08-15 |
| Est. Completion | 2024-06-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06017050
The ClinicalTrials.gov registry entry for NCT06017050 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center for Innovative Public Health Research, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bullying appearing as the primary indexed condition, and to 2 interventions - of which BullyDown is the first listed.
NCT06017050 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, North Carolina.
Frequently Asked Questions
What is clinical trial NCT06017050 about?
NCT06017050 is a clinical study titled "BullyDown, a Text Messaging-based Bullying Prevention Program for Middle School-aged Youth". Given the limited impact of existing school-based interventions and the time associated with implementing them during school time, more efficient and effective intervention methods are needed. Programs that can be delivered to middle school youth irrespective of whether they are attending school phy...
What is the current status of trial NCT06017050?
This trial is currently completed. It is a NA study. The enrollment target is 138 participants. The study started on 2023-08-15. Estimated completion is 2024-06-03.
What conditions does trial NCT06017050 study?
This clinical trial studies the following conditions: Bullying.
What interventions are being tested in trial NCT06017050?
The interventions under investigation include: BullyDown (BEHAVIORAL), Attention-matched control (BEHAVIORAL).
Who is sponsoring clinical trial NCT06017050?
This trial is sponsored by Center for Innovative Public Health Research, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06017050 being conducted?
This trial has 2 study locations across California, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bullying
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.